Trump’s HHS defends drug price negotiations in Novartis suit
Lawyers for the government gave the first substantive signal that the Trump administration will continue to defend Medicare drug price negotiations in court.
In a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.